M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

P/OCF
Price to OCF

-5.8
Current
-6.3
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-5.8
=
Market Cap
104.7m EUR
/
Operating Cash Flow
-18.2m EUR
All Countries
Close
Market Cap P/OCF
FR
Maat Pharma SA
PAR:MAAT
104.7m EUR -5.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -236 050.3
US
Abbvie Inc
NYSE:ABBV
301B USD 18.2
US
Amgen Inc
NASDAQ:AMGN
162B USD 22.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD -135
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -476.6
AU
CSL Ltd
ASX:CSL
138B AUD 32.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 20.8
US
Seagen Inc
F:SGT
39.3B EUR -76.9
NL
argenx SE
XBRU:ARGX
34.1B EUR -138.6
 
FR
M
Maat Pharma SA
PAR:MAAT
Average P/OCF: 21.1
Negative Multiple: -5.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 050.3
US
Abbvie Inc
NYSE:ABBV
18.2
US
Amgen Inc
NASDAQ:AMGN
22.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -135
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -476.6
AU
CSL Ltd
ASX:CSL
32.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.9
NL
argenx SE
XBRU:ARGX
Negative Multiple: -138.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More